ArticleCancers2023

Gene Expressions and High Lymphocyte Count May Predict Durable Clinical Benefits in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Mette T Mouritzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.